Multi-institutional validation of AI models for classifying urothelial neoplasms in digital pathology.
This study presents a deep learning approach using convolutional neural networks and transformer-based models to classif...
Inlexzo (gemcitabine intravesical system): promising data but key questions remain.
- Post category:Genitourinary (Prostate, Bladder) System
- Reading time:1 min read
The FDA approval of Inlexzo (gemcitabine intravesical system) marks a significant advance in bladder-sparing treatment f...
State-of-the-Art Imaging in Antibody-Drug Conjugate Treatment for Advanced Bladder Cancer.
- Post category:Genitourinary (Prostate, Bladder) System
- Reading time:1 min read
This review focuses on the transformative impact of antibody-drug conjugates (ADCs), specifically enfortumab vedotin and...
Advancing Bladder Cancer Management: The Role of Neoadjuvant and Adjuvant Therapies and Biomarkers in Muscle Invasive Bladder Cancer.
- Post category:Genitourinary (Prostate, Bladder) System
- Reading time:1 min read
This publication reviews the rapidly evolving management of muscle-invasive bladder cancer (MIBC), highlighting the crit...
Muscle-Invasive Bladder Cancer: A Watershed Moment.
- Post category:Genitourinary (Prostate, Bladder) System
- Reading time:1 min read
The management of muscle-invasive bladder cancer (MIBC) has significantly advanced, particularly recognizing the challen...
SEOM-SOGUG clinical guideline for urothelial cancer (2025).
- Post category:Genitourinary (Prostate, Bladder) System
- Reading time:1 min read
This 2025 clinical guideline offers evidence-based recommendations for the diagnosis, staging, and management of bladder...